Research

  • Landmark Clinical Trial to Establish the Evidence-Based Use of Regenerative Medicine to Treat Tendon Injury in Dogs

    This landmark study is being performed by the Veterinary Orthopedic and Sports Medicine (VOSM) Group in Annapolis Junction, MD, whose practioners were instrumental in the formation of the newly recognized veterinary specialty of veterinary sports medicine and rehabilitation. As an active, versatile breed, sports related injuries affect a large number

    Continue reading
  • Innovations in Prevention, Diagnosis, and Treatment of Cancer

    Lymphoma and hemangiosarcoma are major health problems in Portuguese Water Dogs. This study collaborates with several top universities and researchers who are utilizing cutting edge technology to identify several regions of the genome that contain genetic, heritable, risk factors for lymphoma and hemangiosarcoma in Golden Retrievers. This information can then

    Continue reading
  • Testing a Potential Therapeutic Target for Lymphoma

    Valosin-Containing Protein (VCP): A Novel Therapeutic Target for Canine Lymphoma Summary: This study investigates a new therapeutic target (valosin-containing protein) for dogs with lymphoma. Description: A cure for canine lymphoma remains elusive, in part because of the lack of molecular-targeted therapies that can circumvent chemotherapy resistance. The research team’s previous

    Continue reading
  • Testing Strategies to Treat Drug-Resistant Hemangiosarcomas

    Lysosomal Drug Sequestration by CSF-1R (High) Tumor Cells Contributes to Drug Resistance in Canine Hemangiosarcoma Summary: Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance. Description: Canine hemangiosarcoma is a common and highly

    Continue reading
  • Exploring the use of a Virus Based Anticancer Strategy for Lymphoma

    A Clinical Trial of VSV-cIFNbeta-NIS Oncolytic Virotherapy for Canine B-Cell Lymphoma Summary: This study explores the safety and effectiveness of a new virus-based therapy, developed at Mayo Clinic, for dogs with B-cell lymphoma. Description: Lymphoma is one of the most commonly occurring malignant tumors in dogs. Though treatable, the disease

    Continue reading
  • Defining the Genetic Basis of Inflammatory Bowel Disease

    Inflammatory Bowel Disease (IBD) is a group of disorders in which the intestinal tract has become invaded with the dog’s own white blood cells leading to inflammation. Over time, this inflammation causes the intestine to become less efficient at absorbing nutrients from digested food and weight loss, and vomiting or

    Continue reading
  • Filling the Gaps in the Canine Genome

    The sequencing of the genome of man’s best friend in 2005 has provided an invaluable resource to the canine research community, and has reinforced the position of the dog as an important model organism to study human physiology and disease. Unlike the human and the rodent models (the mouse and

    Continue reading
  • Beyond the Genome: The Intersection of Genes and the Environment in Canine Cancer

    Not all genes are active at all times. DNA methylation (the addition of methyl groups to DNA) is one of several mechanisms that cells use to control gene expression. Abnormal patterns of DNA methylation have been observed in human cancer. However, methylation remains an unexplored dimension of canine disease. This

    Continue reading
  • Clinical Advancement of a Cancer Vaccine in Dogs

    Canine lymphoma is the most common blood-based cancer in dogs with an estimated annual incidence of 30/100,000. Chemotherapy induces remission in 75-85% of patients; however, the majority of patients relapse with drug-resistant lymphoma within 8-10 months of diagnosis and most dogs die of their disease shortly thereafter. Cell-based vaccine strategies

    Continue reading
  • Disrupting the Differentiation of Cancer Stem Cells to Prevent the Spread of Hemangiosarcoma

    Hemangiosarcoma is a rapidly fatal disease. The lifetime risk is alarmingly high for some breeds like Golden Retrievers (~20% will die of this disease) and Portuguese Water Dogs (~15% will die of this disease). The risk of hemangiosarcoma is not limited to just these breeds but is considered a research

    Continue reading